CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Glioblastoma organoid technology: an emerging preclinical models for drug discovery
Don Carlo Ramos Batara, Shuchang Zhou, Moon-Chang Choi, Sung-Hak Kim
Organoid. 2022;2:e7  Published online February 25, 2022
DOI: https://doi.org/10.51335/organoid.2022.2.e7

Excel Download

Glioblastoma organoid technology: an emerging preclinical models for drug discovery
Organoid. 2022;2:e7   Crossref logo
Link1 Link2 Link3

Fundamental signaling pathways for glioblastoma drug resistance and developing robust organoid models for drug discovery
Organoid. 2022;2:e8   Crossref logo
Link1 Link2 Link3

Organoid Models of Glioblastoma and Their Role in Drug Discovery
Frontiers in Cellular Neuroscience. 2021;15:   Crossref logo
Link1

Drug development using pancreatic and lung organoid models
Animal Models in Cancer Drug Discovery. 2019;323-342   Crossref logo
Link1 Link2

Emerging role and promise of nanomaterials in organoid research
Drug Discovery Today. 2022;27(3):890-899   Crossref logo
Link1 Link2

Emerging technologies for prediction of drug candidate efficacy in the preclinical pipeline
Drug Discovery Today. 2017;22(11):1598-1603   Crossref logo
Link1 Link2

Perspective on the status of preclinical models for psychiatric disorders
Drug Discovery Today: Disease Models. 2005;2(4):279-283   Crossref logo
Link1 Link2

Preclinical models in ovarian cancer
Animal Models in Cancer Drug Discovery. 2019;31-57   Crossref logo
Link1 Link2

Evaluation of hepatocellular carcinoma models for preclinical studies
Drug Discovery Today: Disease Models. 2005;2(1):41-49   Crossref logo
Link1 Link2

Preclinical pharmacology and in vivo models
Cancer Drug Design and Discovery. 2008;39-52   Crossref logo
Link1 Link2